Winship Cancer Institute of Emory University
@winshipcancer.emory.edu
As Georgia’s only NCI-Designated Comprehensive Cancer Center, we are dedicated to the prevention, treatment and control of cancer. #WhereScienceBecomesHope
https://winshipcancer.emory.edu
https://winshipcancer.emory.edu
We’re celebrating one year of Winship’s HDR brachytherapy program at Emory Midtown! 🎉 Since its launch, the program has expanded access to advanced, image-guided cancer care in a state-of-the-art operative suite.
Read more ➡️ brnw.ch/21wW3Jm
Read more ➡️ brnw.ch/21wW3Jm
September 25, 2025 at 2:52 PM
We’re celebrating one year of Winship’s HDR brachytherapy program at Emory Midtown! 🎉 Since its launch, the program has expanded access to advanced, image-guided cancer care in a state-of-the-art operative suite.
Read more ➡️ brnw.ch/21wW3Jm
Read more ➡️ brnw.ch/21wW3Jm
🎉 Winship, through generous support from the Arthur M. Blank Family Foundation and in collaboration with Mount Sinai Health System, celebrated the launch of the new Winship Mobile Prostate Cancer Screening Program today at a community event inside Mercedes-Benz Stadium. ➡️ brnw.ch/21wVpyk
September 2, 2025 at 9:48 PM
🎉 Winship, through generous support from the Arthur M. Blank Family Foundation and in collaboration with Mount Sinai Health System, celebrated the launch of the new Winship Mobile Prostate Cancer Screening Program today at a community event inside Mercedes-Benz Stadium. ➡️ brnw.ch/21wVpyk
Winship epidemiologist Michael Goodman, MD, MPH, collaborates with India’s Center for Chronic Disease Control to strengthen cancer surveillance systems and improve how cases are tracked.
Read more ➡️ brnw.ch/21wV7KI
Read more ➡️ brnw.ch/21wV7KI
August 22, 2025 at 3:29 PM
Winship epidemiologist Michael Goodman, MD, MPH, collaborates with India’s Center for Chronic Disease Control to strengthen cancer surveillance systems and improve how cases are tracked.
Read more ➡️ brnw.ch/21wV7KI
Read more ➡️ brnw.ch/21wV7KI
Winship investigators have been awarded a total of $400,000 to support eight new projects through Winship Invest$, a peer-reviewed program designed to accelerate innovative cancer research. Learn more ➡️ brnw.ch/21wUWPO
August 18, 2025 at 3:10 PM
Winship investigators have been awarded a total of $400,000 to support eight new projects through Winship Invest$, a peer-reviewed program designed to accelerate innovative cancer research. Learn more ➡️ brnw.ch/21wUWPO
One of the biggest challenges in cancer care is when patients stop responding to treatment. A new study led by Mourad Zerfaoui, PhD, reveals how loss of a molecule called AHR fuels drug resistance in BRAF-mutant melanoma and thyroid cancer. 🔗 brnw.ch/21wUGp7
August 6, 2025 at 2:29 PM
One of the biggest challenges in cancer care is when patients stop responding to treatment. A new study led by Mourad Zerfaoui, PhD, reveals how loss of a molecule called AHR fuels drug resistance in BRAF-mutant melanoma and thyroid cancer. 🔗 brnw.ch/21wUGp7
That wraps up the first segment of the lymphoma session at #DDHO2025, closing with a patient-centered panel discussion featuring EHA highlights and a dynamic Q&A.
July 25, 2025 at 1:42 PM
That wraps up the first segment of the lymphoma session at #DDHO2025, closing with a patient-centered panel discussion featuring EHA highlights and a dynamic Q&A.
Debate: early vs delayed transplantation in myelofibrosis
Amelia Langston, MD argues for early ☀️
Michael Hochman, MD argues for delayed ⏰
#DDHO2025
Amelia Langston, MD argues for early ☀️
Michael Hochman, MD argues for delayed ⏰
#DDHO2025
July 24, 2025 at 4:25 PM
Debate: early vs delayed transplantation in myelofibrosis
Amelia Langston, MD argues for early ☀️
Michael Hochman, MD argues for delayed ⏰
#DDHO2025
Amelia Langston, MD argues for early ☀️
Michael Hochman, MD argues for delayed ⏰
#DDHO2025
Are ADCs Highly Promising for the Treatment of NSCLC...or... ADCs are the Futures of NSCLC?
Winship’s Conor E. Steuer, MD argues yes! #DDHO2025
Winship’s Conor E. Steuer, MD argues yes! #DDHO2025
July 24, 2025 at 12:12 PM
Are ADCs Highly Promising for the Treatment of NSCLC...or... ADCs are the Futures of NSCLC?
Winship’s Conor E. Steuer, MD argues yes! #DDHO2025
Winship’s Conor E. Steuer, MD argues yes! #DDHO2025
Winship urologist Vikram Narayan, MD, FACS, was profiled by Apple for Emory Healthcare's use of Apple technology to streamline workflows and enhance patient care. 🎥 Read more and Watch the video ➡️ brnw.ch/21wUcrF
July 17, 2025 at 2:05 PM
Winship urologist Vikram Narayan, MD, FACS, was profiled by Apple for Emory Healthcare's use of Apple technology to streamline workflows and enhance patient care. 🎥 Read more and Watch the video ➡️ brnw.ch/21wUcrF
Winship thoracic oncologist Fatemeh Ardeshir, MD, MSc. commented on the new FDA-approved treatment option, Datroway (datopotamab deruxtecan or Dato-DXd).
The treatment is now available for people with non-small cell lung cancer (NSCLC) who harbor a common EGFR mutation. Learn more: brnw.ch/21wUbRP
The treatment is now available for people with non-small cell lung cancer (NSCLC) who harbor a common EGFR mutation. Learn more: brnw.ch/21wUbRP
July 16, 2025 at 3:25 PM
Winship thoracic oncologist Fatemeh Ardeshir, MD, MSc. commented on the new FDA-approved treatment option, Datroway (datopotamab deruxtecan or Dato-DXd).
The treatment is now available for people with non-small cell lung cancer (NSCLC) who harbor a common EGFR mutation. Learn more: brnw.ch/21wUbRP
The treatment is now available for people with non-small cell lung cancer (NSCLC) who harbor a common EGFR mutation. Learn more: brnw.ch/21wUbRP
🎗️ July is Sarcoma Awareness Month. Sarcomas are rare cancers—making up less than 1% of adult cases—with 150+ types that require expert care.
Sarcoma expert Kenneth Cardona, MD, FACS, says their rarity makes diagnosis and treatment especially challenging. Learn more ➡️ brnw.ch/21wU8tY
Sarcoma expert Kenneth Cardona, MD, FACS, says their rarity makes diagnosis and treatment especially challenging. Learn more ➡️ brnw.ch/21wU8tY
July 14, 2025 at 5:46 PM
🎗️ July is Sarcoma Awareness Month. Sarcomas are rare cancers—making up less than 1% of adult cases—with 150+ types that require expert care.
Sarcoma expert Kenneth Cardona, MD, FACS, says their rarity makes diagnosis and treatment especially challenging. Learn more ➡️ brnw.ch/21wU8tY
Sarcoma expert Kenneth Cardona, MD, FACS, says their rarity makes diagnosis and treatment especially challenging. Learn more ➡️ brnw.ch/21wU8tY
🎉Seventy-three Winship physicians were selected by their peers as "Top Doctors" for Atlanta magazine's 2025 list of the city's best doctors.
July 9, 2025 at 1:35 PM
🎉Seventy-three Winship physicians were selected by their peers as "Top Doctors" for Atlanta magazine's 2025 list of the city's best doctors.
🎊Joining Winship on July 1, breast medical oncologist and cancer survivorship expert Neil M. Iyengar, MD, has been appointed director of survivorship services at Winship Cancer Institute of Emory University.
Read more ➡️ brnw.ch/21wTPea
Read more ➡️ brnw.ch/21wTPea
July 2, 2025 at 3:53 PM
🎊Joining Winship on July 1, breast medical oncologist and cancer survivorship expert Neil M. Iyengar, MD, has been appointed director of survivorship services at Winship Cancer Institute of Emory University.
Read more ➡️ brnw.ch/21wTPea
Read more ➡️ brnw.ch/21wTPea
Winship medical oncologist Kevin Kalinsky, MD, MS, FASCO, discusses how findings from the phase 3 SERENA-6 trial reinforce the importance of timely ESR1 testing in HR-positive breast cancer.
Read more ➡️ brnw.ch/21wTOyy
Read more ➡️ brnw.ch/21wTOyy
July 1, 2025 at 3:51 PM
Winship medical oncologist Kevin Kalinsky, MD, MS, FASCO, discusses how findings from the phase 3 SERENA-6 trial reinforce the importance of timely ESR1 testing in HR-positive breast cancer.
Read more ➡️ brnw.ch/21wTOyy
Read more ➡️ brnw.ch/21wTOyy
“Can I take this supplement?” It’s a common question after a cancer diagnosis—but it’s just one part of a bigger picture. At Winship, Naturopathic Doctor serving as an Integrative Oncology Specialist Anna Bausum, ND, FABNO, helps patients build a strong foundation to support healing. brnw.ch/21wTN9a
June 30, 2025 at 8:37 PM
“Can I take this supplement?” It’s a common question after a cancer diagnosis—but it’s just one part of a bigger picture. At Winship, Naturopathic Doctor serving as an Integrative Oncology Specialist Anna Bausum, ND, FABNO, helps patients build a strong foundation to support healing. brnw.ch/21wTN9a
🎙️Your voice says a lot—sometimes even signals cancer. Winship researcher Anthony Law, MD, PhD is using AI to help primary care doctors detect signs of laryngeal cancer through voice changes—something specialists are trained to hear but others might miss. ➡️ brnw.ch/21wTCiL
June 23, 2025 at 6:19 PM
🎙️Your voice says a lot—sometimes even signals cancer. Winship researcher Anthony Law, MD, PhD is using AI to help primary care doctors detect signs of laryngeal cancer through voice changes—something specialists are trained to hear but others might miss. ➡️ brnw.ch/21wTCiL
Emory hematology and medical oncology fellows Michelle Lee, MD, PhD, and Kingsley Nnawuba, MD, were recognized with @conquercancer.bsky.social awards at the #ASCO25 Annual Meeting. Lee received a Young Investigator Award, and Nnawuba received a Research Award. 👏👏👏
June 12, 2025 at 2:09 PM
Emory hematology and medical oncology fellows Michelle Lee, MD, PhD, and Kingsley Nnawuba, MD, were recognized with @conquercancer.bsky.social awards at the #ASCO25 Annual Meeting. Lee received a Young Investigator Award, and Nnawuba received a Research Award. 👏👏👏
Launched in 2023, Winship's Oncology Nurse Residency Program is designed to provide new nurses with foundational knowledge, practical experience and mentorship to confidently transition to the specialized field of oncology. Learn more 👉 winshipcancer.emory.edu/newsroom/art...
June 9, 2025 at 3:12 PM
Launched in 2023, Winship's Oncology Nurse Residency Program is designed to provide new nurses with foundational knowledge, practical experience and mentorship to confidently transition to the specialized field of oncology. Learn more 👉 winshipcancer.emory.edu/newsroom/art...
🎉 It’s a wrap on #ASCO25! Winship was proud to have a strong presence this year with our booth! 💙🏢🙌
🙏 Thanks to everyone who stopped by to connect with us! 💬💙
🙏 Thanks to everyone who stopped by to connect with us! 💬💙
June 3, 2025 at 3:31 PM
🎉 It’s a wrap on #ASCO25! Winship was proud to have a strong presence this year with our booth! 💙🏢🙌
🙏 Thanks to everyone who stopped by to connect with us! 💬💙
🙏 Thanks to everyone who stopped by to connect with us! 💬💙
Winship breast oncologist Jane Meisel, MD, summarizes yesterday’s #ASCO25 plenary session of the SERENA-6 trial results showing the benefit of using circulating tumor DNA (ctDNA) monitoring to guide treatment changes for patients with HR+/HER2- advanced #breastcancer.
June 2, 2025 at 7:03 PM
Winship breast oncologist Jane Meisel, MD, summarizes yesterday’s #ASCO25 plenary session of the SERENA-6 trial results showing the benefit of using circulating tumor DNA (ctDNA) monitoring to guide treatment changes for patients with HR+/HER2- advanced #breastcancer.
Winship medical oncologist Jacqueline Brown, MD, gives a summary of an abstract discussion she moderated at #ASCO25 on new treatment directions in advanced #bladdercancer.
June 2, 2025 at 5:35 PM
Winship medical oncologist Jacqueline Brown, MD, gives a summary of an abstract discussion she moderated at #ASCO25 on new treatment directions in advanced #bladdercancer.
